William B. O'Connor
2016
In 2016, William B. O'Connor earned a total compensation of $1.7M as Chief Financial Officer at Medicines, a 57% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $287,203 |
| Option Awards | $552,100 |
| Salary | $465,000 |
| Stock Awards | $240,003 |
| Other | $11,164 |
| Total | $1,655,470 |
O'Connor received $552.1K in option awards, accounting for 33% of the total pay in 2016.
O'Connor also received $100K in bonus, $287.2K in non-equity incentive plan, $465K in salary, $240K in stock awards and $11.2K in other compensation.
Rankings
In 2016, William B. O'Connor's compensation ranked 5,787th out of 14,075 executives tracked by ExecPay. In other words, O'Connor earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,787 out of 14,075 | 59th |
Division Manufacturing | 2,099 out of 5,489 | 62nd |
Major group Chemicals And Allied Products | 682 out of 1,895 | 64th |
Industry group Drugs | 511 out of 1,538 | 67th |
Industry Pharmaceutical Preparations | 406 out of 1,176 | 66th |
Source: SEC filing on April 26, 2017.
O'Connor's colleagues
We found four more compensation records of executives who worked with William B. O'Connor at Medicines in 2016.